STOCK TITAN

AIBotics Financials

AIBT
Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows AIBotics (AIBT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI AIBT FY2025

Aibotics operates as a financing-dependent company, where equity issuance keeps cash available far more than business activity does.

The latest year still showed net loss of $2.2M against operating cash burn of only $458K, continuing a recent disconnect between accounting losses and near-term cash usage. That gap implies the pressure is less about immediate cash outflow than about liabilities and accrued claims, which keep eroding equity, squeezing flexibility, and making the balance sheet weaker than the cash burn alone suggests.

The business is being funded from outside rather than by operations: financing cash flow was $529K while cash from operations was -$458K. At the same time, shares outstanding surged between FY2024 and FY2025, showing liquidity was preserved mainly by issuing more equity instead of by building an operating base that could support overhead.

Liquidity is extremely thin: cash was just $256K against $4.8M of current liabilities, so routine obligations dwarf immediately available resources. With negative equity and liabilities still above assets, the company reads less like a self-funding operation and more like an entity that must continuously manage counterparties and capital access just to stay current.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 0 / 100
Financial Profile 0/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of AIBotics's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
0

AIBotics has an operating margin of -84501.7%, meaning the company retains $-84502 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses.

Leverage
0

AIBotics has elevated debt relative to equity (D/E of -1.22), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 0/100, reflecting increased financial risk.

Liquidity
0

AIBotics's current ratio of 0.06 is below the typical benchmark, resulting in a score of 0/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Piotroski F-Score Weak
3/9

AIBotics passes 3 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Low Quality
0.21x

For every $1 of reported earnings, AIBotics generates $0.21 in operating cash flow (-$458K OCF vs -$2.2M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk
-8.1x

AIBotics earns $-8.1 in operating income for every $1 of interest expense (-$1.8M vs $227K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$2K

AIBotics generated $2K in revenue in fiscal year 2025.

EBITDA
-$1.8M
YoY-12.9%

AIBotics's EBITDA was -$1.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 12.9% from the prior year.

Net Income
-$2.2M
YoY-19.9%

AIBotics reported -$2.2M in net income in fiscal year 2025. This represents a decrease of 19.9% from the prior year.

EPS (Diluted)
N/A

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$256K
YoY+38.3%
5Y CAGR+18.2%

AIBotics held $256K in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
441M

AIBotics had 441M shares outstanding in fiscal year 2025. This represents an increase of 1001.8% from the prior year.

Margins & Returns

Gross Margin
100.0%

AIBotics's gross margin was 100.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs.

Operating Margin
-84501.7%

AIBotics's operating margin was -84501.7% in fiscal year 2025, reflecting core business profitability.

Net Margin
-101500.3%

AIBotics's net profit margin was -101500.3% in fiscal year 2025, showing the share of revenue converted to profit.

Return on Equity
N/A

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
N/A

AIBT Income Statement

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Revenue N/A $0 $0-100.0% $2.2M N/A $0 $0 $0
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A $0 $0-100.0% $2.2M N/A $0 $0 $0
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses N/A $480K+33.2% $361K-99.9% $531.6M N/A $385K-1.6% $391K+8.5% $361K
Operating Income N/A -$480K-33.2% -$361K+99.9% -$529.5M N/A -$385K+1.6% -$391K-8.5% -$361K
Interest Expense N/A $11K-84.1% $70K-99.9% $61.9M N/A $75K-5.5% $79K+21.8% $65K
Income Tax N/A $0 $0 $0 N/A $0 $0 $0
Net Income N/A -$530K-9.0% -$486K+99.9% -$591.4M N/A -$460K+2.2% -$471K-10.5% -$426K
EPS (Diluted) N/A N/A N/A N/A N/A N/A N/A N/A

AIBT Balance Sheet

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Total Assets $875K-14.0% $1.0M-14.2% $1.2M-99.9% $1.3B+86681.4% $1.5M-11.3% $1.6M-13.0% $1.9M-12.0% $2.1M
Current Assets $270K+11.9% $241K-0.3% $242K-99.8% $156.7M+84578.3% $185K-8.8% $203K-27.6% $280K-24.4% $371K
Cash & Equivalents $256K+11.1% $230K-4.8% $242K-99.8% $156.7M+84578.3% $185K-8.5% $202K-27.7% $280K-24.4% $370K
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $4.8M-1.4% $4.9M-9.1% $5.4M-99.9% $5.1B+105044.7% $4.9M-3.0% $5.0M+3.9% $4.8M+4.6% $4.6M
Current Liabilities $4.8M-2.2% $4.9M-9.1% $5.4M-99.9% $5.1B+105044.7% $4.9M-3.0% $5.0M+3.9% $4.8M+4.6% $4.6M
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity -$4.0M-1.9% -$3.9M+7.7% -$4.2M+99.9% -$3.8B-112926.0% -$3.4M-1.1% -$3.4M-14.8% -$2.9M-19.2% -$2.5M
Retained Earnings -$13.0M-4.9% -$12.4M-4.5% -$11.9M+99.9% -$11.4B-105371.2% -$10.8M-4.8% -$10.3M-4.7% -$9.9M-5.0% -$9.4M

AIBT Cash Flow Statement

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Operating Cash Flow -$87K+51.5% -$179K-8.6% -$165K+99.4% -$28.4M-164201.0% -$17K+77.7% -$78K+14.3% -$91K-22.8% -$74K
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow N/A N/A $0 $0 N/A $0 $0 $0
Financing Cash Flow $112K-32.9% $167K-33.2% $250K $0 $0 $0 $0-100.0% $165K
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

AIBT Financial Ratios

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Gross Margin N/A N/A N/A 100.0% N/A N/A N/A N/A
Operating Margin N/A N/A N/A -24254.0% N/A N/A N/A N/A
Net Margin N/A N/A N/A -27091.0% N/A N/A N/A N/A
Return on Equity N/A N/A N/A 15.4% N/A N/A N/A N/A
Return on Assets N/A -52.1%-11.1pp -41.0%+5.8pp -46.8% N/A -28.0%-3.1pp -24.9%-5.1pp -19.9%
Current Ratio 0.060.0 0.050.0 0.04+0.0 0.030.0 0.040.0 0.04-0.0 0.06-0.0 0.08
Debt-to-Equity -1.22+0.0 -1.26+0.0 -1.28+0.0 -1.33+0.1 -1.43+0.1 -1.49+0.2 -1.65+0.2 -1.87
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Note: Shareholder equity is negative (-$4.0M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.06), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Frequently Asked Questions

AIBotics (AIBT) reported $2K in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

No, AIBotics (AIBT) reported a net income of -$2.2M in fiscal year 2025, with a net profit margin of -101500.3%.

AIBotics (AIBT) had EBITDA of -$1.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

AIBotics (AIBT) had a gross margin of 100.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

AIBotics (AIBT) had an operating margin of -84501.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

AIBotics (AIBT) had a net profit margin of -101500.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

AIBotics (AIBT) generated -$458K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

AIBotics (AIBT) had $875K in total assets as of fiscal year 2025, including both current and long-term assets.

AIBotics (AIBT) had 441M shares outstanding as of fiscal year 2025.

AIBotics (AIBT) had a current ratio of 0.06 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

AIBotics (AIBT) had a debt-to-equity ratio of -1.22 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

AIBotics (AIBT) had a return on assets of -253.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, AIBotics (AIBT) had $256K in cash against an annual operating cash burn of $458K. This gives an estimated cash runway of approximately 7 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

AIBotics (AIBT) has negative shareholder equity of -$4.0M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

AIBotics (AIBT) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

AIBotics (AIBT) has an earnings quality ratio of 0.21x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

AIBotics (AIBT) has an interest coverage ratio of -8.1x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

AIBotics (AIBT) scores 0 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top